MedTrace Logo

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

NCT01077817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 684815

Last updated 2022-02-03

Study results available
· View outcomes & findings →

Summary

This is a 2-phase retrospective database study, using both case-cohort and inception (intention-to-treat) cohort analyses to evaluate any association between oral treatments for osteoporosis and the risk of esophageal cancer in women.

Conditions

Interventions

DRUG

Alendronate

DRUG

Etidronate

DRUG

Ibandronate

DRUG

Risedronate

DRUG

Raloxifene

Sponsors & Collaborators

  • World Health Information Science Consultants, LLC

    collaborator OTHER

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Alec Walker, MD, DrPH · World Health Information Science Consultants, LLC

Eligibility

Min Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-26
Primary Completion
2012-02-16
Completion
2012-02-16

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01077817 on ClinicalTrials.gov